Urticaria as presenting manifestation of pemphigus herpetiformis.
D000287:Administration, Topical; D000328:Adult; D000632:Aminopyrine / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D010392:Pemphigus / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis*; D011239:Prednisolone; D014581:Urticaria / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis*
D000893:Anti-Inflammatory Agents; D000632:Aminopyrine; D003622:Dapsone; D011239:Prednisolone